Ferro (FOE) completes sale of pharmaceutical business to PLI Holdings for $16.9M in cash and up...


Ferro (FOE) completes sale of pharmaceutical business to PLI Holdings for $16.9M in cash and up to $8M in incentive payments over two years. The company is selling non-core assets as it seeks to pacify skeptical shareholders who believe the company should have accepted what SA contributor Dr. Jacques Saint-Pierre called a "fair" buyout offer last month. 

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs